InMed Pharmaceuticals (FRA:MWG0) Short-Term Capital Lease Obligation : €0.32 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is InMed Pharmaceuticals Short-Term Capital Lease Obligation?

InMed Pharmaceuticals's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.32 Mil.

InMed Pharmaceuticals's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (€0.28 Mil) to Dec. 2023 (€0.33 Mil) but then declined from Dec. 2023 (€0.33 Mil) to Mar. 2024 (€0.32 Mil).

InMed Pharmaceuticals's annual Short-Term Capital Lease Obligation increased from Jun. 2021 (€0.07 Mil) to Jun. 2022 (€0.38 Mil) but then declined from Jun. 2022 (€0.38 Mil) to Jun. 2023 (€0.35 Mil).

InMed Pharmaceuticals Short-Term Capital Lease Obligation Historical Data

The historical data trend for InMed Pharmaceuticals's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMed Pharmaceuticals Short-Term Capital Lease Obligation Chart

InMed Pharmaceuticals Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.06

0.07

0.38

0.35

InMed Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.40	0.35	0.28	0.33	0.32

InMed Pharmaceuticals Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

InMed Pharmaceuticals Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of InMed Pharmaceuticals's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

InMed Pharmaceuticals (FRA:MWG0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InMed Pharmaceuticals Inc (FRA:MWG0) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

INM:USA MWG0:Germany

Address

815 West Hastings Street, Suite 310, Vancouver, BC, CAN, V6C 1B4

Website

https://www.inmedpharma.com

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

InMed Pharmaceuticals (FRA:MWG0) Headlines

No Headlines